Novel selective and metabolically stable inhibitors of anandamide cellular uptake (abst – 2003) http://www.ncbi.nlm.nih.gov/pubmed/12732359
In vivo pharmacological actions of two novel inhibitors of anandamide cellular uptake (abst – 2004)http://www.ncbi.nlm.nih.gov/pubmed/14744610
Development of the first potential covalent inhibitors of anandamide cellular uptake (abst – 2006)http://www.ncbi.nlm.nih.gov/pubmed/16570928
Effects of endocannabinoid neurotransmission modulators on brain stimulation reward (abst – 2006)http://www.ncbi.nlm.nih.gov/pubmed/16953388
STUDIES OF ANANDAMIDE ACCUMULATION INHIBITORS IN CEREBELLAR GRANULE NEURONS (full – 2007)http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2248273/
The role of endocannabinoids in the regulation of gastric emptying: alterations in mice fed a high-fat diet (full – 2008)http://www.ncbi.nlm.nih.gov/pmc/arti...9/?tool=pubmed
Neuronal and glial alterations in the cerebellar cortex of maternally deprived rats: gender differences and modulatory effects of two inhibitors of endocannabinoid inactivation (full – 2008) http://onlinelibrary.wiley.com/doi/1...dneu.20672/pdf
Gender-dependent cellular and biochemical effects of maternal deprivation on the hippocampus of neonatal rats: a possible role for the endocannabinoid system (full – 2008) http://onlinelibrary.wiley.com/doi/1...dneu.20666/pdf
Activity-based anorexia in C57/BL6 mice: effects of the phytocannabinoid, Delta9-tetrahydrocannabinol (THC) and the anandamide analogue, OMDM-2 (abst – 2010) http://www.ncbi.nlm.nih.gov/pubmed/20471226
A new strategy to block tumor angiogenesis by inhibiting endocannabinoid inactivation (abst – 2013)http://www.fasebj.org/cgi/content/me...c-38c0c63c19ad
The administration of endocannabinoid uptake inhibitors OMDM-2 or VDM-11 promotes sleep and decreases extracellular levels of dopamine in rats (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/23238438
In vivo pharmacological actions of two novel inhibitors of anandamide cellular uptake (abst – 2004)http://www.ncbi.nlm.nih.gov/pubmed/14744610
Development of the first potential covalent inhibitors of anandamide cellular uptake (abst – 2006)http://www.ncbi.nlm.nih.gov/pubmed/16570928
Effects of endocannabinoid neurotransmission modulators on brain stimulation reward (abst – 2006)http://www.ncbi.nlm.nih.gov/pubmed/16953388
STUDIES OF ANANDAMIDE ACCUMULATION INHIBITORS IN CEREBELLAR GRANULE NEURONS (full – 2007)http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2248273/
The role of endocannabinoids in the regulation of gastric emptying: alterations in mice fed a high-fat diet (full – 2008)http://www.ncbi.nlm.nih.gov/pmc/arti...9/?tool=pubmed
Neuronal and glial alterations in the cerebellar cortex of maternally deprived rats: gender differences and modulatory effects of two inhibitors of endocannabinoid inactivation (full – 2008) http://onlinelibrary.wiley.com/doi/1...dneu.20672/pdf
Gender-dependent cellular and biochemical effects of maternal deprivation on the hippocampus of neonatal rats: a possible role for the endocannabinoid system (full – 2008) http://onlinelibrary.wiley.com/doi/1...dneu.20666/pdf
Activity-based anorexia in C57/BL6 mice: effects of the phytocannabinoid, Delta9-tetrahydrocannabinol (THC) and the anandamide analogue, OMDM-2 (abst – 2010) http://www.ncbi.nlm.nih.gov/pubmed/20471226
A new strategy to block tumor angiogenesis by inhibiting endocannabinoid inactivation (abst – 2013)http://www.fasebj.org/cgi/content/me...c-38c0c63c19ad
The administration of endocannabinoid uptake inhibitors OMDM-2 or VDM-11 promotes sleep and decreases extracellular levels of dopamine in rats (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/23238438